10 Best Small-Cap Value Stocks to Buy
Small-cap stocks are the real thing in an equity market under immense pressure amid geopolitical and monetary policy uncertainties.
Ani Pharmaceuticals Inc (ANIP)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Soleus Capital Guy Levy | 820,243 | $63,076,687 | +69% | 2.55% |
| 2. | Tang Capital Management Kevin C. Tang | 707,500 | $54,406,750 | +47% | 2.76% |
| 3. | GoldenTree Asset Management Steven Tananbaum | 667,981 | $51,295,618 | 3.04% | |
| 4. | Deep Track Capital David Kroin | 600,000 | $46,140,000 | +26% | 0.75% |
| 5. | Millennium Management Israel Englander | 592,013 | $45,525,800 | +10% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.69 | 7,224 | $199,997.16 | 169,650 | 2022-03-21 | Filing | |
| $27.76 | 5,000 | $138,794.00 | 53,388 | 2022-03-21 | Filing | |
| $27.87 | 5,000 | $139,342.50 | 393,226 | 2022-03-21 | Filing | |
| $27.15 | 5,000 | $135,744.00 | 388,226 | 2022-03-18 | Filing | |
| $27.65 | 5,000 | $138,251.50 | 5,000 | 2022-03-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $80.63 | 10,000 | $806,300.00 | 38,432 | 2026-05-13 | Filing | |
| $80.75 | 3,973 | $320,819.75 | 48,432 | 2026-05-11 | Filing | |
| $79.21 | 459 | $36,357.39 | 38,271 | 2026-05-12 | Filing | |
| $77.57 | 55,000 | $4,266,350.00 | 349,889 | 2026-05-11 | Filing | |
| $79.50 | 2,772 | $220,374.00 | 78,696 | 2026-05-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,747,492 | $211,282,135 | 0% | |
| 2. | 823,064 | $63,293,622 | 0% | |
| 3. | 771,587 | $59,335,040 | 0% | |
| 4. | 40,517,000 | $50,165,112 | 1.71% | |
| 5. | 531,190 | $40,842,741 | 0.01% |
News See All
ANI Pharmaceuticals (ANIP) Announces Launch of Pimozide Tablets 1 mg and 2 mg
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is one of the best drug stocks to buy according to analysts. ANI Pharmaceuticals, Inc.
9 Best Drug Stocks to Buy According to Analysts
On April 27, Jurrien Timmer, director of global macro at Fidelity Investments, appeared on CNBC to talk about the market and oil prices, and how necessary it is for oil prices to retreat from their highs...
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q4 2025 Earnings Call Transcript
Operator: Good day, everyone, and welcome to today's ANI Pharmaceuticals, Inc. Fourth Quarter and Full Year 2025 Earnings Results Call. Please note, this call is being recorded.
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q3 2025 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to today's ANI Pharmaceuticals Third Quarter 2025 Earnings Results Call. Please note, this call is being recorded.
ANI Pharmaceuticals, Inc. (ANIP) Hits Milestone with Cortrophin Gel Prefilled Syringe Launch
ANI Pharmaceuticals, Inc.
11 Best Pharma Stocks to Invest in for the Long Term
According to a recent White House announcement, President Trump wrote letters to 17 major pharmaceutical companies outlining the actions they could take to bring the prices of prescription pharmaceuticals...
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q2 2025 Earnings Call Transcript
Operator: Good day, everyone, and welcome to today's ANI Pharmaceuticals, Inc. 2Q 2025 Earnings Results Call. Please note, this call is being recorded.
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q1 2025 Earnings Call Transcript
Operator: Please stand by. Your program is about to begin. [Operator Instructions] Good day everyone and welcome to today's ANI Pharmaceuticals, Inc. First Quarter 2025 Earnings Results Call.
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q4 2024 Earnings Call Transcript
Operator: Good morning, everyone. Welcome to today's ANI Pharmaceuticals Fourth Quarter 2024 Earnings Results Call. Please note, this call is being recorded.
Hedge Fund Resource Center